Y
HN Search
Hacker News Search
new
|
comments
|
top
|
jobs
aaavl2821
searching PlanetScale…
1.
▲
2.
▲
3.
▲
4.
▲
5.
▲
6.
▲
11 ms
·
1.
▲
Show HN: Catalyst Maze: biotech trading game
(rnpv.baybridgebio.com)
4 points
by
aaavl2821
4mo ago
|
0 comments
2.
▲
Sophistical Refutations
(en.wikipedia.org)
1 points
by
aaavl2821
1y ago
|
0 comments
3.
▲
Sophist
(en.wikipedia.org)
15 points
by
aaavl2821
1y ago
|
5 comments
4.
▲
Can AI predict clinical trial outcomes?
(baybridgebio.com)
2 points
by
aaavl2821
1y ago
|
0 comments
5.
▲
AI won't replace biotech analysts
(baybridgebio.com)
1 points
by
aaavl2821
1y ago
|
0 comments
6.
▲
Show HN: Research Pharma Markets with AI
(baybridgebio.com)
2 points
by
aaavl2821
2y ago
|
0 comments
7.
▲
Show HN: Search for drugs approved to treat a given disease
(baybridgebio.com)
1 points
by
aaavl2821
2y ago
|
0 comments
8.
▲
Better obesity drugs are coming soon
(baybridgebio.com)
2 points
by
aaavl2821
2y ago
|
0 comments
9.
▲
The Future of the Obesity Market
(baybridgebio.com)
1 points
by
aaavl2821
2y ago
|
0 comments
10.
▲
The obesity drug landscape in one chart
(baybridgebio.com)
3 points
by
aaavl2821
2y ago
|
0 comments
11.
▲
A primer on the obesity drug landscape
(baybridgebio.com)
2 points
by
aaavl2821
2y ago
|
0 comments
12.
▲
AI-enabled biotech startup analysis
(baybridgebio.com)
1 points
by
aaavl2821
3y ago
|
0 comments
13.
▲
Analyzing gene therapy startup in layman's terms
(baybridgebio.com)
1 points
by
aaavl2821
3y ago
|
0 comments
14.
▲
AI Analysis of Biotech Startups
(baybridgebio.com)
2 points
by
aaavl2821
3y ago
|
0 comments
15.
▲
AI investment analyst: initiating coverage on Neumora Therapeutics
(baybridgebio.com)
1 points
by
aaavl2821
3y ago
|
0 comments
16.
▲
Quantifying risk / reward in biotech investing
(baybridgebio.com)
1 points
by
aaavl2821
3y ago
|
0 comments
17.
▲
Valuing Biotech Licensing Deals
(baybridgebio.com)
1 points
by
aaavl2821
3y ago
|
0 comments
18.
▲
Show HN: Value Biotech Licensing Deals
(baybridgebio.com)
2 points
by
aaavl2821
3y ago
|
0 comments
19.
▲
Which VCs are still investing in biopharma?
(baybridgebio.com)
1 points
by
aaavl2821
3y ago
|
0 comments
20.
▲
Biotech VC on pace for worst year since 2016
(baybridgebio.com)
2 points
by
aaavl2821
3y ago
|
0 comments
21.
▲
The biotech venture capital crunch
(baybridgebio.com)
1 points
by
aaavl2821
3y ago
|
0 comments
22.
▲
Show HN: Interactive guide to valuing biotech companies
(baybridgebio.com)
2 points
by
aaavl2821
4y ago
|
0 comments
23.
▲
Diagnosing the problem with biotech R&D
(baybridgebio.com)
2 points
by
aaavl2821
4y ago
|
0 comments
24.
▲
Is Biotech Investing Sustainable?
(baybridgebio.com)
1 points
by
aaavl2821
4y ago
|
0 comments
25.
▲
The next generation of biotech VCs
(baybridgebio.com)
2 points
by
aaavl2821
4y ago
|
0 comments
26.
▲
Will a Recession Save Biotech?
(baybridgebio.com)
2 points
by
aaavl2821
4y ago
|
0 comments
27.
▲
Biotech platforms are out, products are back in
(baybridgebio.com)
16 points
by
aaavl2821
4y ago
|
2 comments
28.
▲
Bargain hunting for biotech stocks [video]
(youtube.com)
1 points
by
aaavl2821
4y ago
|
0 comments
29.
▲
Can big pharma buy every biotech startup?
(baybridgebio.com)
1 points
by
aaavl2821
4y ago
|
0 comments
30.
▲
Biotech crossover investors facing steep losses
(baybridgebio.com)
2 points
by
aaavl2821
4y ago
|
0 comments
More ›